Technology
Health
Biotechnology

Cellular Biomedicine Group

$14.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.53 (-3.55%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CBMG and other stocks, options, ETFs, and crypto commission-free!

About CBMG

Cellular Biomedicine Group, Inc. Common Stock, also called Cellular Biomedicine Group, is a clinical stage biopharmaceutical company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. Read More Its technology includes immune system therapy for treatment of cancer indications and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases. The company was founded in 2009 and is headquartered in New York, NY.

Employees
193
Headquarters
New York, New York
Founded
2009
Market Cap
275.05M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
28.39K
High Today
$15.20
Low Today
$14.30
Open Price
$14.89
Volume
22.08K
52 Week High
$25.00
52 Week Low
$12.04

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Therapy
Cancer Prevention
Pharmaceutical

CBMG Earnings

-$0.56
-$0.52
-$0.48
-$0.44
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.